Complera (emtricitabine and rilpivirine and tenofovir): It would be unlikely that Complera (emtricitabine and rilpivirine and tenofovir) would cause any fat redistribution or abnormal distribution. What prompts the concern?
Answered 2/23/2018
4.1k views
2 doctors weighed in across 2 answers
A doctor has provided 1 answer
2 doctors weighed in across 2 answers
3 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question